Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing
2026-03-04 12:32:46 ET
On February 17, 2026, Opaleye Management Inc. reported selling out its entire stake in Immunome (NASDAQ:IMNM) , an estimated $37.30 million trade based on quarterly average pricing.
According to its SEC filing dated February 17, 2026, Opaleye Management Inc. sold all 3,185,000 shares of Immunome during the fourth quarter of 2025. The estimated transaction value is $37.30 million, based on the average share price over the quarter. This move resulted in the fund holding no remaining shares of Immunome at the end of the reporting period. The quarter-end position value dropped by $37.30 million, reflecting the stake’s full removal.
The fund exited its Immunome position, which previously represented 5.3% of 13F assets under management; following the transaction, Immunome accounts for none of the portfolio (percent of AUM: n/a).
NASDAQ: IMNM
IMNM Trading
0.14% G/L:
$20.58 Last:
383,287 Volume:
$20.65 Open:
